p53 Expression in Canine Liposarcoma Correlates With Myxoid Variant and Higher Proliferative Activity.
Animals
Biomarkers, Tumor
/ metabolism
Cell Differentiation
Cell Proliferation
Cell Transformation, Neoplastic
Dog Diseases
/ classification
Dogs
Immunohistochemistry
/ veterinary
Ki-67 Antigen
/ metabolism
Liposarcoma
/ classification
Mitotic Index
Proto-Oncogene Proteins c-mdm2
/ metabolism
Sarcoma
/ classification
Tumor Suppressor Protein p53
/ metabolism
dogs
immunohistochemistry
liposarcoma
p53
soft tissue sarcoma
Journal
Veterinary pathology
ISSN: 1544-2217
Titre abrégé: Vet Pathol
Pays: United States
ID NLM: 0312020
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
4
8
2020
medline:
27
4
2021
entrez:
4
8
2020
Statut:
ppublish
Résumé
Canine liposarcoma is classified as well differentiated (WDL), dedifferentiated (DDL), myxoid (ML), and pleomorphic (PL). Overexpression of the protooncogene MDM2 has been reported in WDL and DDL, but little is known regarding the role of p53 in their tumorigenesis. The aim of this study was to assess p53 expression in canine liposarcoma and compare it with subtype, grade, mitotic count (MC), Ki67 labeling index (LI), and MDM2 expression. Forty-seven cases were included (13 WDL, 3 DDL, 7 ML, and 24 PL); 17 were MDM2-positive (13 WDL, 3DDL, and 1ML). Five were p53-positive (4 ML and 1 WDL) but DDL and PL were consistently negative. p53 expression correlated with higher Ki67-LI, higher MC, and myxoid histotype. No correlation was found with grade and MDM2 expression. Based on these results canine liposarcoma seems to embody a group of neoplasms whose subtypes, especially ML, may represent distinct diseases rather than morphological variants of the same entity.
Identifiants
pubmed: 32744152
doi: 10.1177/0300985820941501
doi:
Substances chimiques
Biomarkers, Tumor
0
Ki-67 Antigen
0
Tumor Suppressor Protein p53
0
Proto-Oncogene Proteins c-mdm2
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM